David Pitt

6.3k total citations · 1 hit paper
64 papers, 4.5k citations indexed

About

David Pitt is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Immunology. According to data from OpenAlex, David Pitt has authored 64 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pathology and Forensic Medicine, 22 papers in Molecular Biology and 14 papers in Immunology. Recurrent topics in David Pitt's work include Multiple Sclerosis Research Studies (33 papers), Neuroinflammation and Neurodegeneration Mechanisms (12 papers) and RNA regulation and disease (10 papers). David Pitt is often cited by papers focused on Multiple Sclerosis Research Studies (33 papers), Neuroinflammation and Neurodegeneration Mechanisms (12 papers) and RNA regulation and disease (10 papers). David Pitt collaborates with scholars based in United States, Canada and Australia. David Pitt's co-authors include Cedric S. Raine, Peter Werner, Gerald Ponath, Calvin Park, Yi Wang, Susan A. Gauthier, David A. Hafler, Sriram Ramanan, William Housley and Aaron Boster and has published in prestigious journals such as Nature Medicine, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

David Pitt

64 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Glutamate excitotoxicity in a model of multiple sclerosis

2000 703 citations David Pitt, Peter Werner et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Pitt United States	31	1.9k	1.3k	1.2k	929	751	64	4.5k
Corline J.A. De Groot Netherlands	32	1.6k 0.9×	1.4k 1.1×	1.1k 0.9×	1.2k 1.3×	463 0.6×	52	4.3k
Federico Roncaroli United Kingdom	45	1.9k 1.0×	1.3k 1.0×	1.8k 1.6×	817 0.9×	483 0.6×	210	7.2k
Henning Laursen Denmark	37	1.6k 0.9×	1.0k 0.8×	1.5k 1.3×	441 0.5×	508 0.7×	118	5.5k
Simon Hametner Austria	27	2.2k 1.2×	1.2k 1.0×	1.0k 0.9×	606 0.7×	825 1.1×	66	4.0k
Josa M. Frischer Austria	22	2.3k 1.2×	1.2k 0.9×	1.1k 1.0×	655 0.7×	302 0.4×	58	4.2k
Bruno Stankoff France	39	2.6k 1.4×	1.1k 0.9×	1.4k 1.2×	414 0.4×	732 1.0×	129	5.8k
Istvan Pirko United States	30	1.9k 1.0×	724 0.6×	689 0.6×	522 0.6×	465 0.6×	64	3.3k
Ansi Chang United States	23	2.9k 1.5×	1.8k 1.4×	2.1k 1.9×	875 0.9×	502 0.7×	25	6.4k
Don Mahad United Kingdom	35	2.3k 1.2×	2.1k 1.7×	2.3k 2.0×	1.4k 1.5×	240 0.3×	56	6.6k
Romana Höftberger Austria	49	2.7k 1.4×	1.5k 1.2×	2.2k 1.9×	855 0.9×	600 0.8×	173	8.6k

Countries citing papers authored by David Pitt

Since Specialization

Citations

This map shows the geographic impact of David Pitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Pitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Pitt more than expected).

Fields of papers citing papers by David Pitt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Pitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Pitt. The network helps show where David Pitt may publish in the future.

Co-authorship network of co-authors of David Pitt

This figure shows the co-authorship network connecting the top 25 collaborators of David Pitt. A scholar is included among the top collaborators of David Pitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Pitt. David Pitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zeng, Jialiu, et al.. (2025). Lysosomal acidification impairment in astrocyte-mediated neuroinflammation. Journal of Neuroinflammation. 22(1). 72–72. 7 indexed citations

Colombo, Emanuela, Marco Bacigaluppi, Daniela Triolo, et al.. (2024). Astrocyte TrkB promotes brain injury and edema formation in ischemic stroke. Neurobiology of Disease. 201. 106670–106670. 3 indexed citations

Wang, Qin, Elizabeth Mills, Qi Wu, et al.. (2024). Siponimod Attenuates Neuronal Cell Death Triggered by Neuroinflammation via NFκB and Mitochondrial Pathways. International Journal of Molecular Sciences. 25(5). 2454–2454. 4 indexed citations

Manouchehri, Navid, Afsaneh Shirani, Victor H. Salinas, et al.. (2022). Clinical trials in multiple sclerosis: past, present, and future. Neurologia i Neurochirurgia Polska. 56(3). 228–235. 4 indexed citations

Manouchehri, Navid, et al.. (2022). Efficacy of Disease Modifying Therapies in Progressive MS and How Immune Senescence May Explain Their Failure. Frontiers in Neurology. 13. 854390–854390. 14 indexed citations

Rui, Jinxiu, Songyan Deng, Ana Luisa Perdigoto, et al.. (2021). Tet2 Controls the Responses of β cells to Inflammation in Autoimmune Diabetes. Nature Communications. 12(1). 5074–5074. 19 indexed citations

Park, Calvin, Gerald Ponath, Eric Swanson, et al.. (2019). The landscape of myeloid and astrocyte phenotypes in acute multiple sclerosis lesions. Acta Neuropathologica Communications. 7(1). 130–130. 42 indexed citations

Swanberg, Kelley M., Karl Landheer, David Pitt, & Christoph Juchem. (2019). Quantifying the Metabolic Signature of Multiple Sclerosis by in vivo Proton Magnetic Resonance Spectroscopy: Current Challenges and Future Outlook in the Translation From Proton Signal to Diagnostic Biomarker. Frontiers in Neurology. 10. 1173–1173. 46 indexed citations

Deh, Kofi, Gerald Ponath, Kelly M. Gillen, et al.. (2018). Magnetic susceptibility increases as diamagnetic molecules breakdown: Myelin digestion during multiple sclerosis lesion formation contributes to increase on QSM. Journal of Magnetic Resonance Imaging. 48(5). 1281–1287. 34 indexed citations

10.

Gillen, Kelly M., Mayyan Mubarak, Thanh D. Nguyen, & David Pitt. (2018). Significance and In Vivo Detection of Iron-Laden Microglia in White Matter Multiple Sclerosis Lesions. Frontiers in Immunology. 9. 255–255. 64 indexed citations

11.

Deleidi, Michela, David Pitt, Kedar Mahajan, et al.. (2015). Concise Review: Modeling Multiple Sclerosis With Stem Cell Biological Platforms: Toward Functional Validation of Cellular and Molecular Phenotypes in Inflammation-Induced Neurodegeneration. Stem Cells Translational Medicine. 4(3). 252–260. 17 indexed citations

12.

Boster, Aaron, Yaz Y. Kisanuki, Wei Pei, et al.. (2013). Lessons Learned From Fatal Progressive Multifocal Leukoencephalopathy in a Patient With Multiple Sclerosis Treated With Natalizumab. JAMA Neurology. 70(3). 398–398. 20 indexed citations

13.

Chen, Weiwei, Susan A. Gauthier, Ajay Gupta, et al.. (2013). Quantitative Susceptibility Mapping of Multiple Sclerosis Lesions at Various Ages. Radiology. 271(1). 183–192. 184 indexed citations

14.

Pitt, David, et al.. (2011). T1 and proton density at 7 T in patients with multiple sclerosis: an initial study. Magnetic Resonance Imaging. 30(1). 19–25. 17 indexed citations

15.

Pitt, David, Aaron Boster, Pei Wei, et al.. (2010). Imaging Cortical Lesions in Multiple Sclerosis With Ultra–High-Field Magnetic Resonance Imaging. Archives of Neurology. 67(7). 812–8. 173 indexed citations

16.

Gaupp, Stefanie, David Pitt, William A. Kuziel, Barbara Cannella, & Cedric S. Raine. (2003). Experimental Autoimmune Encephalomyelitis (EAE) in CCR2−/− Mice. American Journal Of Pathology. 162(1). 139–150. 106 indexed citations

17.

Werner, Peter, David Pitt, & Cedric S. Raine. (2001). Multiple sclerosis: Altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Annals of Neurology. 50(2). 169–180. 387 indexed citations

18.

Werner, P., David Pitt, & Cedric S. Raine. (2000). Glutamate excitotoxicity — a mechanism for axonal damage and oligodendrocyte death in Multiple Sclerosis?. PubMed. 375–385. 76 indexed citations

19.

Cannella, B., David Pitt, Elisabetta Capello, & Cedric S. Raine. (2000). Insulin-Like Growth Factor-1 Fails to Enhance Central Nervous System Myelin Repair during Autoimmune Demyelination. American Journal Of Pathology. 157(3). 933–943. 60 indexed citations

20.

Fehmann, Hans-Christoph, et al.. (1996). Ligand-Induced Regulation of Glucagon-like Peptide-I Receptor Function and Expression in Insulin-Secreting β Cells. Pancreas. 13(3). 273–282. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact